Toll-like receptor variants are associated with infant HIV-1 acquisition and peak plasma HIV-1 RNA level

AIDS

Volumn 27, Issue 15, 2013, Pages 2431-2439

  Beima Sofie, Kristin M ^a   Bigham, Abigail W ^c   Lingappa, Jairam R ^a,b   Wamalwa, Dalton ^e   Mackelprang, Romel D ^a   Bamshad, Michael J ^a,b   Maleche Obimbo, Elizabeth ^e   Richardson, Barbra A ^a,d   John Stewart, Grace C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d USA   (United States)

^e UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

Genetic epidemiology; HIV genetics; Innate immunity; Mother to child transmission; Pediatric HIV; Single nucleotide polymorphisms; Toll like receptors

Indexed keywords

VIRUS RNA;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNAL PLASMA; MORTALITY; MYELOID DIFFERENTIATION FACTOR 88 GENE; NEWBORN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TIRAP GENE; TOLL LIKE RECEPTOR 2 GENE; TOLL LIKE RECEPTOR 3 GENE; TOLL LIKE RECEPTOR 4 GENE; TOLL LIKE RECEPTOR 7 GENE; TOLL LIKE RECEPTOR 8 GENE; TOLL LIKE RECEPTOR 9 GENE; TOLL LIKE RECEPTOR GENE; VIRUS LOAD;

DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; KENYA; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, VIRAL; SEX FACTORS; TIME FACTORS; TOLL-LIKE RECEPTORS; VIRAL LOAD;

EID: 84884476196     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283629117     Document Type: Article

References (35)

1. Ploquin MJ, Jacquelin B, Jochems SP, Barre-Sinoussi F, Muller-Trutwin MC. Innate immunity in the control of HIV/AIDS: recent advances and open questions. AIDS 2012; 26:1269-1279.
2. Mogensen TH, Melchjorsen J, Larsen CS, Paludan SR. Innate immune recognition and activation during HIV infection. Retrovirology 2010; 7:54.
3. Chang JJ, Altfeld M. Innate immune activation in primary HIV-1 infection. J Infect Dis 2010; 202 (Suppl 2):S297-S301.
4. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801.
5. Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009; 21:317-337.
6. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21:335-376.
7. Murphy K, Travers P, Walport M. Immuno biology. 7th ed. New York: Garland Science; 2008.
8. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11:373-384.
9. Bowie AG, Haga IR. The role of Toll-like receptors in the host response to viruses. Mol Immunol 2005; 42:859-867.
10. Oh DY, Baumann K, Hamouda O, Eckert JK, Neumann K, Kucherer C, et al. A frequent functional Toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression. AIDS 2009; 23:297-307.
11. Oh DY, Taube S, Hamouda O, Kucherer C, Poggensee G, Jessen H, et al. A functional Toll-like receptor 8 variant is associated with HIV disease restriction. J Infect Dis 2008; 198:701-709.
12. Soriano-Sarabia N, Vallejo A, Ramirez-Lorca R, Rodriguez Mdel M, Salinas A, Pulido I, et al. Influence of the Toll-like receptor 9 1635A/G polymorphism on the CD4 count, HIV viral load, and clinical progression. J Acquir Immune Defic Syndr 2008; 49:128-135.
13. Bochud PY, Hersberger M, Taffe P, Bochud M, Stein CM, Rodrigues SD, et al. Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS 2007; 21:441-446.
14. Pine SO, McElrath MJ, Bochud PY. Polymorphisms in Toll-like receptor 4 and Toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals. AIDS 2009; 23:2387-2395.
15. Sironi M, Biasin M, Cagliani R, Forni D, De Luca M, Saulle I, et al. A common polymorphism in TLR3 confers natural resistance to HIV-1 infection. J Immunol 2012; 188:818-823.
16. Freguja R, Gianesin K, Del Bianco P, Malacrida S, Rampon O, Zanchetta M, et al. Polymorphisms of innate immunity genes influence disease progression in HIV-1-infected children. AIDS 2012; 26:765-768.
17. Ricci E, Malacrida S, Zanchetta M, Mosconi I, Montagna M, Giaquinto C, et al. Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1. J Transl Med 2010; 8:49.
18. Sanders CM, Cruse JM, Lewis RE. Toll-like receptors, cytokines and HIV-1. Exp Mol Pathol 2008; 84:31-36.
19. Lester RT, Yao XD, Ball TB, McKinnon LR, Kaul R, Wachihi C, et al. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS 2008; 22:685-694.
20. Farquhar C, Rowland-Jones S, Mbori-Ngacha D, Redman M, Lohman B, Slyker J, et al. Human leukocyte antigen (HLA) BM18 and protection against mother-to-child HIV type 1 transmission. AIDS Res Hum Retroviruses 2004; 20:692-697.
21. Farquhar C, VanCott TC, Mbori-Ngacha DA, Horani L, Bosire RK, Kreiss JK, et al. Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk. J Infect Dis 2002; 186:1173-1176.
22. Otieno PA, Brown ER, Mbori-Ngacha DA, Nduati RW, Farquhar C, Obimbo EM, et al. HIV-1 disease progression in breastfeeding and formula-feeding mothers: a prospective 2-year comparison of T cell subsets, HIV-1 RNA levels, and mortality. J Infect Dis 2007; 195:220-229.
23. Lohman BL, Slyker J, Mbori-Ngacha D, Bosire R, Farquhar C, Obimbo E, et al. Prevalence and magnitude of human immunodeficiency virus (HIV) type 1-specific lymphocyte responses in breast milk from HIV-1-seropositive women. J Infect Dis 2003; 188:1666-1674.
24. Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 1999; 353:773-780.
25. Emery S, Bodrug S, Richardson BA, Giachetti C, Bott MA, Panteleeff D, et al. Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J Clin Microbiol 2000; 38:2688-2695.
26. International HapMap Consortium. A haplotype map of the human genome. Nature 2005; 437:1299-1320.
27. International HapMap Consortium. The International HapMap Project. Nature 2003; 426:789-796.
28. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38:904-909.
29. Mackelprang RD, Bigham AW, Celum C, de Bruyn G, Beima-Sofie K, John-Stewart G, et al. Polymorphisms in TLR2 and TLR7 are associated with plasma HIV-1 RNA set point in an African heterosexual cohort (abstract). 19th International AIDS Conference, Washington, DC, 2012.
30. Chang JJ, Lacas A, Lindsay RJ, Doyle EH, Axten KL, Pereyra F, et al. Differential regulation of Toll-like receptor pathways in acute and chronic HIV-1 infection. AIDS 2012; 26:533-541.
31. Obimbo EM, Wamalwa D, Richardson B, Mbori-Ngacha D, Overbaugh J, Emery S, et al. Pediatric HIV-1 in Kenya: pattern and correlates of viral load and association with mortality. J Acquir Immune Defic Syndr 2009; 51:209-215.
32. Tao K, Fujii M, Tsukumo S, Maekawa Y, Kishihara K, Kimoto Y, et al. Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis 2007; 66:905-909.
33. Sauna ZE, Kimchi-Sarfaty C. Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet 2011; 12:683-691.
34. Matt C, Roger M. Genetic determinants of pediatric HIV-1 infection: vertical transmission and disease progression among children. Mol Med 2001; 7:583-589.
35. Tiemessen CT, Kuhn L. Immune pathogenesis of pediatric HIV-1 infection. Curr HIV/AIDS Rep 2006; 3:13-19.